Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Clinical trial NCT02607865 · COMPLETED
Trial details
- NCT number
- NCT02607865
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-15
- Primary completion
- 2017-02-14
- Enrollment
- 1864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.